| 000 | 01182nam a2200349 a 4500 | ||
|---|---|---|---|
| 001 | vtls001469921 | ||
| 003 | NLI | ||
| 005 | 20210627130252.0 | ||
| 008 | 121201s1981 dcua f000 0 eng | ||
| 039 | 9 |
_y201212011855 _zVLOAD |
|
| 040 |
_aNLI _beng _cDatasoft_FOD _eAACR2 |
||
| 041 | 0 | _aeng | |
| 044 | _a dcu | ||
| 082 | 0 | 4 | _a 616.925 |
| 110 | 1 |
_aUnited States. _bDepartment of Health and Human Services _9707894 |
|
| 245 | 1 | 0 |
_aViral immunology / _cedited by Abner Louis Notkins |
| 260 |
_aWashington, D. C. : _bThe Departement, _c1981 |
||
| 300 |
_a23 p. : _bill. ; _c26 cm. |
||
| 440 | 0 |
_aICRDB cancer gram series ; _vCB 13, no. 81/04 _9728638 |
|
| 650 | 0 |
_aVirus diseases _xImmunological aspects _91023129 |
|
| 650 | 0 |
_aImmunopathology _9778857 |
|
| 650 | 0 |
_aViral Vaccines _9927830 |
|
| 650 | 0 |
_aVirus diseases _xImmunology _91023130 |
|
| 650 | 0 |
_aVirus diseases _xDrug therapy _91023131 |
|
| 700 | 1 |
_aNotkins, Abner Louis, _4edt _91024809 |
|
| 887 | _a | ||
| 901 |
_aAD 111594 _b05.10.2010 _9vCB 13,no.81/04 |
||
| 902 | _aU.S 616.925 Un 3 | ||
| 904 | _lF 6701 | ||
| 949 |
_AVIRTUAITEM _D10002 _X100 _6FOD000111594ENG _9vcb 13no.81/04. |
||
| 942 |
_2ddc _cBKS |
||
| 999 |
_aVIRTUA40 _c919086 _d919086 |
||